Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises
In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (CDMO). However, underneath all those metrics, a single truth remains: if quality fails, so does everything else. read more
Future-Proofing Pharmacovigilance in an AI Era
Clinical research organizations (CROs) are entering an era in which pharmacovigilance systems are doing more than just tracking copious amounts of data. They must also keep pace with evolving regulations, manage the growing volume of adverse event reports, and respond to heightened scrutiny from both regulators and the public. read more
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to 2030
The global pharmaceutical sterile and prefilled syringe market has experienced remarkable growth in recent years, fueled by technological advances and evolving therapeutic needs. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Kindeva Names Chief Legal Officer
Tuesday, March 10, 2026
Kindeva announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate... read more
Lonza to Divest Capsules & Health Ingredients – Become Pure-Play CDMO
Tuesday, March 10, 2026
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of... read more
Neuland to Open Commercial Peptide Facility as Part of Planned Phased Expansion
Tuesday, March 10, 2026
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with ... read more
Naobios and SGS Partner to Manufacture Respiratory Syncytial Virus (RSV) Challenge Agent
Tuesday, March 10, 2026
Naobios and SGS announce their partnership in the manufacturing of a Respiratory Syncytial Virus (RSV) challenge agent for use in Controlled Human ... read more
Frontage Laboratories Completes Acquisition of Teddy Lab
Thursday, March 05, 2026
Frontage Laboratories announced the completion of the acquisition of Teddy Clinical Research Laboratory, a clinical research laboratory service ... read more